Translational Pathology Core Facility The Translational Pathology (Core) Laboratory (TPL) is designed to meet the needs of basic, clinical, and population scientists who require analysis of human tissues. TPL provides access to formalin-fixed, paraffin embedded tissues from UNC Hospitals, histopathology services, tissue and cell microarrays, morphological evaluation, morphology-based assays (immunohistochemistry, immunofluorescence, in-situ hybridization, and fluorescence in-situ hybridization), assay development &training, and digital imaging and image analysis for spatial quantification of molecular analytes in intact specimens. TPL is led by Drs. C Ryan Miller (Faculty Director), a leader in translational research and molecular analyses of tissues, and Nana Nikolaishvili-Feinberg (Facility Director), a researcher with experience in all morphological assays and digital image analyses. The LCCC has made significant investments in the TPL to expand services, to purchase forward-looking equipment, to increase capacity through additional staffing, and to develop informatics infrastructure to facilitate case identification, workflow improvements, and integration of digital images and quantitative image analysis data. The latter will allow integration of data from morphology-based assays with those from OMICS technologies. Core use expanded significantly in 2007-2009, in capacity and total service units performed. This year, 51 Pis from eight different LCCC research programs and 36 clinical trials utilized the Core. In 2009, total use was 29,975 service units (80% LCCC members). For 2010, the Center requests $175,126 for personnel and other expenses to support this Core, a 63% increase from 2009, to be allocated towards additional personnel and maintenance contract costs for both existing and newly acquired equipment. Access to and utilization of this core facility will promote the translation of basic science findings to human cancers and permit clinical investigators to perform innovative clinical trials using molecular correlates and endpoints. It will serve population scientists with molecular epidemiology studies on large numbers of samples that require morphological evaluation and assays. Future plans include acquisition of additional automated image analysis equipment and informatics integration with the Bioinformatics Core databases through the LCCC Data Warehouse.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-37
Application #
8392178
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
37
Fiscal Year
2013
Total Cost
$235,108
Indirect Cost
$72,662
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Smith, Jennifer S; Des Marais, Andrea C; Deal, Allison M et al. (2018) Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States. Sex Transm Dis 45:42-48
Morris, Michael J; Rumble, R Bryan; Basch, Ethan et al. (2018) Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36:1521-1539
Hisada, Yohei; Thålin, Charlotte; Lundström, Staffan et al. (2018) Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients. Thromb Res 165:1-5
Westmoreland, Katherine D; El-Mallawany, Nader K; Kazembe, Peter et al. (2018) Dissecting heterogeneous outcomes for paediatric Burkitt lymphoma in Malawi after anthracycline-based treatment. Br J Haematol 181:853-854
Kulis, Michael; Yue, Xiaohong; Guo, Rishu et al. (2018) High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children. Clin Exp Allergy :
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Lund, Jennifer L; Sanoff, Hanna K; Peacock Hinton, Sharon et al. (2018) Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States. Cancer Epidemiol Biomarkers Prev 27:41-49
Wu, Shih-Ying; Fix, Samantha M; Arena, Christopher B et al. (2018) Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery. Phys Med Biol 63:035002
Juliano, Rudolph L; Wang, Ling; Tavares, Francis et al. (2018) Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides. Nucleic Acids Res 46:1601-1613
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7

Showing the most recent 10 out of 1525 publications